08:59 AM EDT, 04/15/2026 (MT Newswires) -- Health care stocks were advancing pre-bell Wednesday with the State Street Health Care Select Sector SPDR ETF (XLV) and iShares Biotechnology ETF (IBB) up 0.1%.

Mesoblast (MESO) shares were up more than 4% after the company said it acquired an exclusive worldwide license to a chimeric antigen receptor technology platform for augmentation of therapeutic mesenchymal lineage stromal cell products.